Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Telmisartan + Hydrochlorothiazide
- Therapeutic area
- Cardiovascular
- Drug class
- Angiotensin receptor blockers
- ATC
- C09DA
- Strength
- 80 mg + 25 mg
- Dosage form
- Tablet
- Pack
- 14
- Registration no.
- 065684
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-12 02:58
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Misar-h (Telmisartan + Hydrochlorothiazide) is used for
Telmisartan with hydrochlorothiazide is a prescription tablet that puts two blood pressure medicines together. Telmisartan is an angiotensin II receptor blocker (ARB): it relaxes and widens the blood vessels. Hydrochlorothiazide is a thiazide diuretic, or "water tablet": it helps the kidneys get rid of extra salt and water in the urine. Together they lower blood pressure more than either one alone. It controls high blood pressure but does not cure it.
- High blood pressure (hypertension) in adults
- Used when telmisartan on its own has not brought blood pressure down enough
- Can also replace telmisartan and hydrochlorothiazide taken as separate tablets
Get medical help straight away if
- Get emergency help for signs of a severe allergic reaction or angioedema: swelling of the face, lips, tongue or throat, trouble breathing or swallowing, or chest tightness.
- Get urgent help for severe shortness of breath or trouble breathing, especially if you have had breathing or lung problems with hydrochlorothiazide before.
- Get urgent help for reduced vision or eye pain. This can be a sign of fluid behind the eye or raised pressure in the eye, which can cause permanent loss of sight if not treated quickly.
- Stop taking it and see a doctor straight away for blistering or peeling skin.
Side effects, warnings and interactions for Telmisartan + Hydrochlorothiazide
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
About Misar-h 80 mg + 25 mg tablet
Misar-h 80 mg + 25 mg tablet contains Telmisartan + Hydrochlorothiazide 80 mg + 25 mg. It is registered with DRAP by Highnoon Laboratories Ltd (registration no. 065684). Its official price is PKR 1,200.88 for a pack of 14, about PKR 85.78 per tablet. This price has applied since 27 July 2026. Misar-h is also available as 40 mg + 12.5 mg tablet and 80 mg + 12.5 mg tablet. 11 other brands of Telmisartan + Hydrochlorothiazide 80 mg + 25 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of Misar-h
All 11 other brands of Telmisartan + Hydrochlorothiazide 80 mg + 25 mg tablet in Pakistan
These 11 brands are alternatives (substitutes) to Misar-h: each contains Telmisartan + Hydrochlorothiazide 80 mg + 25 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is Co-TelBar (Barrett Hodgson Pakistan (Pvt.) Ltd) at PKR 48.81 per tablet; the highest is Velmon-H at PKR 89.88. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Co-TelBar | Barrett Hodgson Pakistan (Pvt.) Ltd | 14's | PKR 683.29 | PKR 48.81 / tablet |
| Telzide | Remington Pharmaceutical Industries (Pvt) Ltd | 2x7's | PKR 725.46 | PKR 51.82 / tablet |
| MICARDIM-HC | Wilshire Laboratories (Private) Limited | 14s | PKR 891.82 | PKR 63.70 / tablet |
| Telysa-H | Scilife Pharma Private Limited | 14's | PKR 947.38 | PKR 67.67 / tablet |
| CO-TIOCARDIS | Atco Laboratories Limited | 28's | PKR 2,164.77 | PKR 77.31 / tablet |
| Teli-H | Wilson's Pharmaceuticals | 14's | PKR 1,089.48 | PKR 77.82 / tablet |
| Co-Ezitab | Werrick Pharmaceuticals | 14's | PKR 1,089.49 | PKR 77.82 / tablet |
| CRESAR-H 80 | TABROS PHARMA (PVT). LTD | 14's | PKR 1,218.37 | PKR 87.03 / tablet |
| Telsitan- H | Macter International Limited | 14's | PKR 1,258.32 | PKR 89.88 / tablet |
| Co-Telnip | The Searle Company Limited | 14's | PKR 1,258.32 | PKR 89.88 / tablet |
| Velmon-H | Martin Dow Limited | 14's | PKR 1,258.32 | PKR 89.88 / tablet |
See every strength and form of Telmisartan + Hydrochlorothiazide →
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Misar-h, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Highnoon Laboratories Ltd, Lahore
- DRAP registration
- 065684
- Phone
- +92 42 111 000 465
- info@highnoon.com.pk
- Website
- https://highnoon-labs.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (14). Current price PKR 1,200.88, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Misar-h 80 mg + 25 mg, 14: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/misar-h-80-mg-25-mg-065684-14-highnoon-laboratories-ltd/ (accessed 12 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,200.88 | 2026-07-27 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Cite this record
Medicine record · DRAP registration 065684Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
